Prevention

This report provides information on the National Immunization Survey (NIS) which estimated vaccination coverage among children aged 19-35 months for 50 states and selected local areas. It describes the 2008 NIS coverage estimates for the 4:3:1:3:3:1 series and individual vaccines, 7-valent pneumococcal conjugate vaccine, =2 dose of Hepatitis A vaccine, and hepatitis B vaccine among children born during January 2005 - June 2007. Results demonstrate that the nation’s immunization program remained successful in maintaining high vaccination rates among young children.

This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.

In this study, CDC reports on assessed hepatitis A vaccine coverage among children aged 12-23 months from 2006-2009, using data from eight Immunization Information System sentinel sites. Average hepatitis A vaccination coverage with =1 dose at the sites increased from 17 percent in 2006 to 47 percent in 2009. Average full vaccination coverage with =2 vaccine doses through age 23 months increased from one percent in 2006 to 15 percent in 2009. Vaccine coverage with =1 dose increased most during 2006 through the first quarter of 2007, then slowed.

This Power Point presentation contains 181 slides that provide guidelines for the prevention and control of TB in correctional facilities, as recommended by CDC.

This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.

Dr. Mark Gilbert of the BC Centre for Disease Control talks about tuberculosis in a minute-long video.

An infographic with information on latent TB, TB disease, TB in British Columbia, TB globally, and TB symptoms,

Dr. Mark Gilbert of the BC Centre for Disease Control talks about the prevalence of tuberculosis in British Columbia.

A fact sheet on the TB skin test, including information on latent TB infection, TB disease, and what a positive/negative skin test means. The fact sheet also has information on testing after receiving the BCG vaccine.

This report on HIV prevention interventions designed for and conducted among women of color in the United States is the third in a series of systematic reviews of HIV/AIDS prevention interventions for people of color throughout the United States. The report is based on evaluated research literature. It presents epidemiological information on HIV/AIDS in the United States among the following women: African American, Latina/Hispanic, Asian American and Pacific Islander, and Native American and Alaskan Native.